These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7732896)

  • 1. Discovery of a better aspirin.
    Isakson P; Seibert K; Masferrer J; Salvemini D; Lee L; Needleman P
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():49-54. PubMed ID: 7732896
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression and selective inhibition of constitutive and inducible forms of cyclooxygenase.
    Seibert K; Masferrer J; Zhang Y; Leahy K; Hauser S; Gierse J; Koboldt C; Anderson G; Bremer M; Gregory S
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():125-7. PubMed ID: 7794421
    [No Abstract]   [Full Text] [Related]  

  • 3. Cox-2-selective inhibitors: the new super aspirins.
    DeWitt DL
    Mol Pharmacol; 1999 Apr; 55(4):625-31. PubMed ID: 10101019
    [No Abstract]   [Full Text] [Related]  

  • 4. The development of COX2 inhibitors.
    Flower RJ
    Nat Rev Drug Discov; 2003 Mar; 2(3):179-91. PubMed ID: 12612644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COX-2 inhibitors--is there cause for concern?
    Seibert K; Lefkowith J; Tripp C; Isakson P; Needleman P
    Nat Med; 1999 Jun; 5(6):621-2. PubMed ID: 10371498
    [No Abstract]   [Full Text] [Related]  

  • 6. 3-Formylchromones: potential antiinflammatory agents.
    Khan KM; Ambreen N; Mughal UR; Jalil S; Perveen S; Choudhary MI
    Eur J Med Chem; 2010 Sep; 45(9):4058-64. PubMed ID: 20576329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [COX-1 and COX-2: functions and pharmacological effects].
    Hinz B; Brune K
    Pharm Unserer Zeit; 1999 Jan; 28(1):21-9. PubMed ID: 10078026
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazole series.
    Song Y; Connor DT; Sercel AD; Sorenson RJ; Doubleday R; Unangst PC; Roth BD; Beylin VG; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
    J Med Chem; 1999 Apr; 42(7):1161-9. PubMed ID: 10197960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A better understanding of anti-inflammatory drugs based on isoforms of cyclooxygenase (COX-1 and COX-2).
    Vane JR; Botting RM
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():41-8. PubMed ID: 7537433
    [No Abstract]   [Full Text] [Related]  

  • 10. [The yin yang of inflammation: inducible and constitutive cyclooxygenase. Nimesulide and selective inhibitors of inducible cyclooxygenase].
    Cirino G; Coppini A; Bigini C; Mitchell JA
    Eur Rev Med Pharmacol Sci; 1998; 2(3 Suppl 1):1-8. PubMed ID: 10887524
    [No Abstract]   [Full Text] [Related]  

  • 11. The future of NSAID therapy: selective COX-2 inhibitors.
    Vane JR; Botting RM
    Int J Clin Pract; 2000; 54(1):7-9. PubMed ID: 10750251
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series.
    Song Y; Connor DT; Doubleday R; Sorenson RJ; Sercel AD; Unangst PC; Roth BD; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
    J Med Chem; 1999 Apr; 42(7):1151-60. PubMed ID: 10197959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,2-Diarylimidazoles as potent, cyclooxygenase-2 selective, and orally active antiinflammatory agents.
    Khanna IK; Weier RM; Yu Y; Xu XD; Koszyk FJ; Collins PW; Koboldt CM; Veenhuizen AW; Perkins WE; Casler JJ; Masferrer JL; Zhang YY; Gregory SA; Seibert K; Isakson PC
    J Med Chem; 1997 May; 40(11):1634-47. PubMed ID: 9171873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How do aspirin and company work? Cyclooxygenases--point of attack of nonsteroidal antirheumatics].
    Steinhilber D
    Pharm Unserer Zeit; 2002; 31(2):140-4. PubMed ID: 11977449
    [No Abstract]   [Full Text] [Related]  

  • 15. New cyclooxygenase-2/5-lipoxygenase inhibitors. 3. 7-tert-butyl-2, 3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations at the 5 position.
    Janusz JM; Young PA; Ridgeway JM; Scherz MW; Enzweiler K; Wu LI; Gan L; Chen J; Kellstein DE; Green SA; Tulich JL; Rosario-Jansen T; Magrisso IJ; Wehmeyer KR; Kuhlenbeck DL; Eichhold TH; Dobson RL
    J Med Chem; 1998 Aug; 41(18):3515-29. PubMed ID: 9719605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From indomethacin to a selective COX-2 inhibitor. Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors.
    Lau CK; Black WC; Belley M; Chan C; Charleson S; Denis D; Gauthier JY; Gordon R; Guay D; Hamel P; Kargman S; Leblanc Y; Mancini J; Ouellet M; Percival D; Prasit P; Roy P; Skorey K; Tagari P; Vickers P; Wong E
    Adv Exp Med Biol; 1997; 407():73-8. PubMed ID: 9321934
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors].
    Tishler M; Langevetiz P; Nesher G
    Harefuah; 2002 Oct; 141(10):920-1. PubMed ID: 12420601
    [No Abstract]   [Full Text] [Related]  

  • 18. (-)-Epiafzelechin: cyclooxygenase-1 inhibitor and anti-inflammatory agent from aerial parts of Celastrus orbiculatus.
    Min KR; Hwang BY; Lim HS; Kang BS; Oh GJ; Lee J; Kang SH; Lee KS; Ro JS; Kim Y
    Planta Med; 1999 Jun; 65(5):460-2. PubMed ID: 10418338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New anti-inflammatory analgetics--are they needed?].
    Paakkari I
    Duodecim; 1999; 115(20):2217-24. PubMed ID: 11973925
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.